Evolent Health Inc (EVH) - Total Liabilities
Based on the latest financial reports, Evolent Health Inc (EVH) has total liabilities worth $1.48 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Evolent Health Inc - Total Liabilities Trend (2012–2025)
This chart illustrates how Evolent Health Inc's total liabilities have evolved over time, based on quarterly financial data. See Evolent Health Inc (EVH) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Evolent Health Inc Competitors by Total Liabilities
The table below lists competitors of Evolent Health Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Grand Pacific Petrochemical Corp
TW:1312
|
Taiwan | NT$30.11 Billion |
|
Shaanxi Xinghua Chemistry Co Ltd
SHE:002109
|
China | CN¥5.83 Billion |
|
Kolon Corp
KO:002020
|
Korea | ₩4.72 Trillion |
|
Taier Heavy Industry Co Ltd
SHE:002347
|
China | CN¥1.16 Billion |
|
IEI Integration Corp
TW:3022
|
Taiwan | NT$3.95 Billion |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥123.67 Million |
|
Shutterstock
NYSE:SSTK
|
USA | $774.90 Million |
|
Ooma Inc
NYSE:OOMA
|
USA | $130.97 Million |
Liability Composition Analysis (2012–2025)
This chart breaks down Evolent Health Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see EVH market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.32 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.74 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.79 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Evolent Health Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Evolent Health Inc (2012–2025)
The table below shows the annual total liabilities of Evolent Health Inc from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $1.48 Billion | -3.83% |
| 2024-12-31 | $1.54 Billion | -4.31% |
| 2023-12-31 | $1.61 Billion | +68.35% |
| 2022-12-31 | $957.88 Million | +31.97% |
| 2021-12-31 | $725.83 Million | -15.09% |
| 2020-12-31 | $854.84 Million | +50.24% |
| 2019-12-31 | $568.97 Million | +6.76% |
| 2018-12-31 | $532.92 Million | +100.05% |
| 2017-12-31 | $266.39 Million | -7.41% |
| 2016-12-31 | $287.73 Million | +255.50% |
| 2015-12-31 | $80.94 Million | +100.60% |
| 2014-12-31 | $40.35 Million | -43.12% |
| 2013-12-31 | $70.93 Million | +538.85% |
| 2012-12-31 | $11.10 Million | -- |
About Evolent Health Inc
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics an… Read more